Identify risk and begin care
before baby arrives
HerCare™ is an EHR-integrated maternal health platform that automatically identifies and prioritizes anemic pregnant patients for early intervention.
Maternal anemia affects up to 1 in 4 pregnant women. Despite being identifiable and treatable, it remains one of the most under-addressed conditions in prenatal care.
Patients Flagged
18 today
Care Plans Generated
7 this week
HerCare™ Maternal Worklist
Real-time EHR risk monitoring
Active Cases
41
High Priority
12
Care Plans Sent
29
Anemia Prevalence
44%
Patient Worklist - Priority Score
ActiveMaria Torres
Iron-Def • Anemia • Recent Preg
23w2d
10.8
19
117
HIGHAisha Williams
Iron-Def • Anemia
28w1d
11.2
22
84
MEDSandra Okonkwo
Iron-Def • HR-Age
31w4d
11.8
28
63
LOWMaternal anemia is common, preventable, and under-addressed
Iron deficiency in pregnancy is associated with serious complications for both mother and baby, yet many health systems lack the tools to detect and manage it proactively.
Many cases of anemia go undetected during routine prenatal visits. By the time it is identified, treatment options are often limited, leading to costly and urgent interventions.
Three steps to better maternal outcomes
HerCare™ works 24/7 through its integration with your EHR, automating identification and management of at-risk maternal patients.
Automatically identify at-risk patients
HerCare™ identifies patients with potential maternal health risks and automatically generates real-time risk assessments and alerts, enabling earlier intervention. Patients are triaged using a proprietary scoring tool that surfaces the most urgent cases in a virtual worklist.
Generate custom, end-to-end care plans
Care plans and medication orders are generated for provider review and returned bi-directionally to the EHR, ensuring communication is provided to all stakeholders in the continuum of care. Individualized treatment plans are created from critical patient data.
Monitor outcomes and impact
Access a library of quality and performance reports to assess patient enrollment trends, performance of maternal anemia screening, opportunities for process improvement, and financial length of stay and readmission impact.
IV iron: A Transformative Approach to Maternal Anemia Management
Unlike oral supplements, which are often slow and poorly tolerated, IV iron delivers rapid improvement in hemoglobin levels. HerCare™ identifies the right patients early so treatment can begin before complications arise.
Rapid hemoglobin improvement
Significant results in 1-2 infusions, enabling proactive vs. reactive treatment
Safe for second and third trimester
Better tolerated than oral iron with a stronger clinical response
Measurable financial return
Treating 30% of anemic patients in a 1,000-pregnancy practice generates $47,600 in IV iron revenue alone
IV Iron Aligns with Quality Measures
Reduced maternal blood transfusions
Aligns with patient blood management and maternal hemorrhage bundles
Reduced preterm birth rates
Supports neonatal safety and NICU avoidance
Improved patient-reported outcomes
Addresses fatigue and recovery post-delivery
Supports health equity
Targets a condition with disproportionate impact in underserved populations
A clear business case for early intervention
Proactive IV iron therapy turns clinical outcomes into financial advantages. The benefits below reflect a conservative model and do not include readmission or length of stay savings.
Conservative ROI Snapshot
Based on 1,000 pregnancies annually
* ROI does not include readmission and length of stay savings. Savings percentages are significantly conservative.
The impact of early maternal risk detection
HerCare™ empowers clinicians with the tools to act before complications arise, improving outcomes for both mother and baby.
Early Risk Identification
Proactively detect potential maternal health risks, from preeclampsia to gestational diabetes, empowering clinicians to intervene before complications arise.
Improved Patient Outcomes
Reduce unnecessary blood transfusions, preterm deliveries, and postpartum hemorrhage and fatigue, enhancing the well-being of both mother and baby.
Supports Health Equity
Decrease racial disparity in maternal outcomes by targeting anemia, which is more prevalent and has a disproportionate impact in underserved populations.
Improved Reimbursement Rates
Prevent avoidable transfusions and preterm labor costs to help meet CMS and payor targets and improve reimbursement for maternal services.
hc1's Anemia Management program enabled us to standardize care and improve patient outcomes. With HerCare™, we are driving better patient care, while also improving the bottom line.
Chief Medical Officer — Pennsylvania Health System
HerCare™ is built on hc1's proven blood management foundation
HerCare™ is a module within hc1's MyBloodHealth platform, which has a track record of measurable clinical and financial impact across health systems nationwide.
8,000+
Blood transfusion complications avoided
1,900+
Transfusion-associated deaths avoided
$120M+
Savings on blood acquisition costs
2.6x
ROI over 3 years on comprehensive solution
Epic
athenahealthReady to close the gap in maternal care?
See how HerCare™ can integrate with your EHR and start identifying at-risk maternal patients today.
See HerCare™ in Action
The industry leader in lab intelligence. Our hc1 IQ™ AI-powered platform transforms diagnostic data into actionable insights for healthcare organizations nationwide.